BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 780K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

14 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
51
Novel arylalkenylpropargylamines as neuroprotective, potent, and selective monoamine oxidase B inhibitors for the treatment of Parkinson's disease.EBI
A*Star
50
Update on the Development of MNK Inhibitors as Therapeutic Agents.EBI
A*Star
16
Novel Halomethylketone Azadipeptides for Treating COVID-19.EBI
A*Star
42
Design, Synthesis, and Preclinical Evaluation of Fused Pyrimidine-Based Hydroxamates for the Treatment of Hepatocellular Carcinoma.EBI
A*Star
56
Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2.EBI
A*Star
1
Substrate-based peptidomimetic inhibitors of the Murray Valley encephalitis virus NS2B/NS3 serine protease: a P1-P4 SAR study.EBI
A*Star
52
Fragment-Based Drug Discovery of Potent Protein Kinase C Iota Inhibitors.EBI
A*Star
26
Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia.EBI
A*Star
119
Compounds useful as inhibitors of isoprenylcysteine carboxyl methyltransferaseBDB
A*Star
94
Therapeutic compounds and methods of use thereofBDB
A*Star
15
A head-to-head comparison of the inhibitory activities of 15 peptidomimetic SARS-CoV-2 3CLpro inhibitors.BDB
A*Star
47
2,4,5-tri-substituted azole-based casein kinase 1 inhibitors as inducers for cardiomyogenesisBDB
A*Star
132
Bicyclic heterocyclic derivatives as MNK1 and MNK2 modulators and uses thereofBDB
A*Star
19
Structure-activity relationship studies of phenanthridine-based Bcl-XL inhibitors.BDB
A*Star